DK1181027T3 - Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri - Google Patents
Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluriInfo
- Publication number
- DK1181027T3 DK1181027T3 DK00935478T DK00935478T DK1181027T3 DK 1181027 T3 DK1181027 T3 DK 1181027T3 DK 00935478 T DK00935478 T DK 00935478T DK 00935478 T DK00935478 T DK 00935478T DK 1181027 T3 DK1181027 T3 DK 1181027T3
- Authority
- DK
- Denmark
- Prior art keywords
- hyperoxaluria
- dietetic
- prevention
- treatment
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000338A IT1309427B1 (it) | 1999-05-28 | 1999-05-28 | Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1181027T3 true DK1181027T3 (da) | 2004-08-16 |
Family
ID=11406789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00935478T DK1181027T3 (da) | 1999-05-28 | 2000-05-24 | Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri |
Country Status (34)
Country | Link |
---|---|
US (2) | US6562336B2 (uk) |
EP (1) | EP1181027B1 (uk) |
JP (1) | JP4737836B2 (uk) |
KR (1) | KR100781703B1 (uk) |
CN (1) | CN100350919C (uk) |
AR (1) | AR024555A1 (uk) |
AT (1) | ATE265857T1 (uk) |
AU (1) | AU773459B2 (uk) |
BR (1) | BR0011038B1 (uk) |
CA (1) | CA2373255C (uk) |
CZ (1) | CZ20014076A3 (uk) |
DE (1) | DE60010456T2 (uk) |
DK (1) | DK1181027T3 (uk) |
DZ (1) | DZ3165A1 (uk) |
EA (1) | EA004257B1 (uk) |
EE (1) | EE200100618A (uk) |
ES (1) | ES2219344T3 (uk) |
HK (1) | HK1048066B (uk) |
HU (1) | HU225134B1 (uk) |
IL (3) | IL146703A0 (uk) |
IS (1) | IS6150A (uk) |
IT (1) | IT1309427B1 (uk) |
MA (1) | MA26790A1 (uk) |
MX (1) | MXPA01012184A (uk) |
NO (1) | NO20015782L (uk) |
NZ (1) | NZ516020A (uk) |
PL (1) | PL352014A1 (uk) |
PT (1) | PT1181027E (uk) |
SI (1) | SI1181027T1 (uk) |
SK (1) | SK16612001A3 (uk) |
TR (1) | TR200103439T2 (uk) |
UA (1) | UA71621C2 (uk) |
WO (1) | WO2000072855A2 (uk) |
ZA (1) | ZA200110504B (uk) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1283225B1 (it) * | 1996-03-11 | 1998-04-16 | Renata Maria Anna Ve Cavaliere | Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle |
US8486389B2 (en) | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
US8697051B2 (en) * | 1999-06-09 | 2014-04-15 | Vsl Pharmaceuticals Inc. | Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
ITRM20010763A1 (it) * | 2001-12-21 | 2003-06-21 | Simone Claudio De | Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono. |
US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
US9655932B2 (en) | 2002-03-13 | 2017-05-23 | Kibow Biotech, Inc. | Composition and method for preventing or treating gout or hyperuricemia |
US11103542B2 (en) | 2002-03-13 | 2021-08-31 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
EP1649863A1 (en) * | 2003-06-24 | 2006-04-26 | Otsuka Pharmaceutical Co., Ltd. | Composition for lowering serum uric acid level |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
DK1732395T3 (en) * | 2004-03-19 | 2015-10-26 | Dupont Nutrition Biosci Aps | EMULSIFIED probiotic |
EP1814995A2 (en) * | 2004-10-27 | 2007-08-08 | North Carolina State University | Lactobacillus acidophilus nucleic acids and uses thereof |
EP1885383B1 (en) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Feline probiotic bifidobacteria |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
JP5047190B2 (ja) | 2005-12-14 | 2012-10-10 | オクセラ インコーポレイテッド | シュウ酸塩関連疾患を治療または予防するための医薬組成物および方法 |
EP2366402A1 (en) | 2005-12-16 | 2011-09-21 | OxThera, Inc., | Compositions and methods for oxalate reduction |
MX2009010187A (es) * | 2007-03-27 | 2009-10-19 | Procter & Gamble | Metodos y estuches para administracion de probioticos. |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CN101606952B (zh) * | 2008-06-17 | 2012-09-19 | 上海交通大学医学院附属第三人民医院 | 乳双歧杆菌在制备预防泌尿系统结石药物中的应用 |
US9283252B2 (en) | 2008-09-30 | 2016-03-15 | Meiji Co., Ltd. | Lactic acid bacterium having high oxalic acid decomposition ability |
CN101554237B (zh) * | 2009-03-16 | 2013-11-06 | 武汉康复得生物科技有限公司 | 植物纤维或微生物不溶组分中的草酸降解酶的制备方法 |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
IT1403661B1 (it) | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI20110791A1 (it) * | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
ITMI20121173A1 (it) * | 2012-07-04 | 2014-01-05 | Neupharma Srl | Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
ITMI20130795A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat |
JP5765832B2 (ja) * | 2013-12-26 | 2015-08-19 | 雪印メグミルク株式会社 | 加齢に伴う代謝異常症の予防・改善・治療剤 |
PL3237600T3 (pl) * | 2014-10-01 | 2020-11-16 | Triphase Pharmaceuticals Pvt. Ltd. | Termostabilne szczepy, ich produkty i sposoby stosowania |
ITUB20155752A1 (it) | 2015-11-19 | 2017-05-19 | Probiotical Spa | Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli. |
CN107868776A (zh) | 2016-09-23 | 2018-04-03 | 武汉康复得生物科技股份有限公司 | 糖基化草酸脱羧酶及其制备和应用 |
WO2018125735A1 (en) | 2016-12-29 | 2018-07-05 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
AU2019396366A1 (en) * | 2018-12-10 | 2021-07-15 | Tenza, Inc. | Methods and compositions for treating hyperoxaluria |
CN113308416B (zh) * | 2021-07-20 | 2023-02-24 | 四川大学 | 一株具有抑制肾结石形成能力的植物乳杆菌及其应用 |
CN115851508B (zh) * | 2022-10-13 | 2024-01-09 | 山东中科嘉亿生物工程有限公司 | 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5810520A (ja) * | 1981-07-10 | 1983-01-21 | Miyarisan Kk | 胆石症の治療薬 |
DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
IT1283225B1 (it) * | 1996-03-11 | 1998-04-16 | Renata Maria Anna Ve Cavaliere | Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle |
ATE169456T1 (de) * | 1996-12-23 | 1998-08-15 | Sitia Yomo Spa | Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung |
CA2288709C (en) * | 1997-05-23 | 2010-05-18 | Ixion Biotechnology, Inc. | Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
RU2139346C1 (ru) * | 1999-03-02 | 1999-10-10 | Шендеров Борис Аркадьевич | Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии |
-
1999
- 1999-05-28 IT IT1999RM000338A patent/IT1309427B1/it active
-
2000
- 2000-05-24 EA EA200101262A patent/EA004257B1/ru not_active IP Right Cessation
- 2000-05-24 NZ NZ516020A patent/NZ516020A/xx unknown
- 2000-05-24 DZ DZ003165A patent/DZ3165A1/xx active
- 2000-05-24 SK SK1661-2001A patent/SK16612001A3/sk unknown
- 2000-05-24 BR BRPI0011038-8A patent/BR0011038B1/pt not_active IP Right Cessation
- 2000-05-24 ES ES00935478T patent/ES2219344T3/es not_active Expired - Lifetime
- 2000-05-24 JP JP2000620965A patent/JP4737836B2/ja not_active Expired - Fee Related
- 2000-05-24 KR KR1020017014857A patent/KR100781703B1/ko not_active IP Right Cessation
- 2000-05-24 CA CA002373255A patent/CA2373255C/en not_active Expired - Fee Related
- 2000-05-24 IL IL14670300A patent/IL146703A0/xx unknown
- 2000-05-24 WO PCT/IT2000/000213 patent/WO2000072855A2/en not_active Application Discontinuation
- 2000-05-24 AT AT00935478T patent/ATE265857T1/de active
- 2000-05-24 HU HU0201409A patent/HU225134B1/hu not_active IP Right Cessation
- 2000-05-24 TR TR2001/03439T patent/TR200103439T2/xx unknown
- 2000-05-24 AU AU51016/00A patent/AU773459B2/en not_active Ceased
- 2000-05-24 UA UA2001129040A patent/UA71621C2/uk unknown
- 2000-05-24 CZ CZ20014076A patent/CZ20014076A3/cs unknown
- 2000-05-24 PL PL00352014A patent/PL352014A1/xx not_active Application Discontinuation
- 2000-05-24 EE EEP200100618A patent/EE200100618A/xx unknown
- 2000-05-24 PT PT00935478T patent/PT1181027E/pt unknown
- 2000-05-24 AR ARP000102552A patent/AR024555A1/es not_active Application Discontinuation
- 2000-05-24 CN CNB008081824A patent/CN100350919C/zh not_active Expired - Fee Related
- 2000-05-24 SI SI200030363T patent/SI1181027T1/xx unknown
- 2000-05-24 EP EP00935478A patent/EP1181027B1/en not_active Expired - Lifetime
- 2000-05-24 DE DE60010456T patent/DE60010456T2/de not_active Expired - Lifetime
- 2000-05-24 DK DK00935478T patent/DK1181027T3/da active
- 2000-05-24 MX MXPA01012184A patent/MXPA01012184A/es active IP Right Grant
-
2001
- 2001-11-08 MA MA26402A patent/MA26790A1/fr unknown
- 2001-11-08 IS IS6150A patent/IS6150A/is unknown
- 2001-11-22 IL IL146703A patent/IL146703A/en not_active IP Right Cessation
- 2001-11-26 US US09/992,029 patent/US6562336B2/en not_active Ceased
- 2001-11-27 NO NO20015782A patent/NO20015782L/no not_active Application Discontinuation
- 2001-12-21 ZA ZA200110504A patent/ZA200110504B/xx unknown
-
2003
- 2003-01-07 HK HK03100152.1A patent/HK1048066B/zh not_active IP Right Cessation
-
2005
- 2005-02-04 US US11/050,623 patent/USRE39585E1/en not_active Expired - Lifetime
-
2009
- 2009-06-18 IL IL199437A patent/IL199437A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1181027T3 (da) | Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri | |
EE200100480A (et) | Ksenoon kasutamiseks närvimürgistuste ravis | |
NO20016304L (no) | Erytropoetinkonjugater med polyetylenglykol, fremstilling av slike konjugater, preparater omfattende slike konjugater samt anvendelse av slike konjugater for fremstilling av medikamenter for forebygging eller behandling av sykdom | |
DK1117394T3 (da) | Anvendelse af carnitiner og resveratrol til fremstilling af et præparat til forebyggelse eller terapeutisk behandling af cerabrale lidelser forårsaget af aldring og anvendelse af neurotoksiske medikamenter | |
NO995500L (no) | Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi | |
PT1228028E (pt) | Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular | |
NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
IS6378A (is) | Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau | |
DK1218022T3 (da) | Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba | |
NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
NO20001905D0 (no) | Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater | |
EE9900034A (et) | Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine | |
NO20022022D0 (no) | N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
NO20016404D0 (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
DK1216035T3 (da) | Tilberedning indeholdende aktive stoffer og/eller hjælpestoffer med kontrolleret frigivelse af disse stoffer og anvendelse og fremstilling deraf | |
NO20014692D0 (no) | 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav | |
PT1073431E (pt) | Utlizacao de antagonistas de nmda no tratamento da sindroma do intestino irritavel | |
IT1306179B1 (it) | Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale. | |
EE200200142A (et) | Heterotsükliliselt asendatud bensoüülguanidiinid,nende saamine ja kasutamine ravimite valmistamiseks ning neid sisaldav ravim | |
NO20021241D0 (no) | Farmasöytiske og/eller kosmetiske blandinger | |
HUP0002154A3 (en) | Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression | |
DK1064014T3 (da) | Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor | |
DK1140090T3 (da) | Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt | |
FI990736A (fi) | Suoja- tai säilöntäainekoostumus, sen valmistusmenetelmä sekä sen käyttö | |
AU2000261604A1 (en) | Liquid or semi-solid pharmaceutical excipient and pharmaceutical composition comprising the same |